To amend the Federal Food, Drug, and Cosmetic Act to improve the regulatory review process to determine the safety and effectiveness of nonprescription drugs intended for topical administration, and for other purposes.
119th Congress
Introduced Jul 29, 2025
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
Jul 29, 2025
Ms. Hassan (for herself and Mr. Marshall) introduced the following …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology